CMMI
-
Cell and Gene, CMMI, Drug shortages, DTC, FDA, Pharmacy Benefit Managers, State-based Reform, Supply Chain, Utilization ManagementAMP is WAC — 04/24/26
Read more: AMP is WAC — 04/24/26Stick a fork in me, I am done with this week. It was a busy week and then you add in a chief of staff (Eddie, the dog) that would whine every 2 hours at night to go outside to deal with a stomach issue and I’m toast. On one hand, #grateful, but ready for…
-
AMP is WAC — 04/10/26
Read more: AMP is WAC — 04/10/26Dam. What a few weeks. I Whistlered while I worked, but the avalanche of news has been hard to keep up with. (I mean, I found it funny.) If you’re interested, I’m hosting a free webinar on April 23 at 12 EST on Most Favored Nation. Quick 30-minute dive. Link to register is here: https://us06web.zoom.us/webinar/register/WN_iPlbMuS5RmeGSbcB8RSi-g…
-
340B, Affordable Care Act, Alzheimer’s, Biosimilars, Cell and Gene, CMMI, FDA, Inflation Reduction Act, Medicare Part D, ObesityAMP is WAC — 03/13/26
Read more: AMP is WAC — 03/13/26The Bigger They Are, the Faster They Grow. A new white paper from Health Capital Group, sponsored by Johnson & Johnson, analyzed HRSA’s OPAIS database from 2017 through 2023 and found something many observers of the 340B program have suspected for years; size is the dominant variable. Hospitals in the top quartile by bed size…
-
Biosimilars, Caught my eye, CMMI, Drug Prices, Employers, Medicare Advantage, Pharmacy Benefit Managers, Reference PricingAMP is WAC — 1/22/26
Read more: AMP is WAC — 1/22/26I swear that inside I’m an 8-year-old at times (one that likes to make cocktails, but still), I am so excited about a snowstorm. Real snowfall! Cozy inside time interspersed with time shoveling out alongside neighbors. Watching the kids sled in front of the elementary school. Pulling out the snowshoes and remembering that they aren’t…
-
340B, Caught my eye, CMMI, Drug Prices, FDA, Healthcare Costs, Inflation Reduction Act, Medicare Advantage, Medicare Negotiation, Medicare Part D, Orphan Drugs, Pharmacy Benefit Managers, Reference Pricing, ValueAMP is WAC — 1/16/26
Read more: AMP is WAC — 1/16/26In case you thought I’d leaving you hanging, today’s newsletter has a summary on GLOBE. Sphere it below? Calling it a Plan would be GENEROUS, but that’s a Whole Other Thing. On Thursday, the White House released a fact sheet urging Congress to enact President Trump’s “Great Healthcare Plan,” pitching it as a cost-cutting package…
-
340B, Caught my eye, CMMI, Drug Prices, FDA, Generics, Inflation Reduction Act, Medicare Negotiation, Medicare Part D, Medicare Transaction Facilitator, Medicare Transaction Facilitator, Obesity, Reference PricingAMP is WAC — 1/9/26
Read more: AMP is WAC — 1/9/26Something is bugging me this week. Okay, lots of things are bugging me this week, but the one that is relevant to this newsletter is the STAT News headline that implied it is awesome to be a pharmaceutical executive in 2026. This week, there were reports of more than 25,000 layoffs in pharma last year.…
-
GUARD Duty
Read more: GUARD DutyConfession. I was a bit of angry elf on Saturday morning. I was making dozens of cookies for neighbors and was just stressed and frustrated. Two proposed rules on a Friday afternoon are never fun, during the holiday season, brutal. My husband said that I had to be more in the moment. Try putting some…
-
340B, Affordable Care Act, Caught my eye, CMMI, Drug Prices, Healthcare Costs, ICER, Medicare Part D, Pharmacy Benefit Managers, Reference Pricing, State-based Reform, Utilization ManagementAMP is WAC — 12/19/25
Read more: AMP is WAC — 12/19/25Today we’re expecting to hear more about manufacturer Most Favored Nation (MFN) agreements and (if you trust the rumors) maybe more about the MFN demos – the Global Benchmark for Efficient Drug Pricing (GLOBE) Model and the Guarding U.S. Medicare Against Rising Drug Costs (GUARD) Model. I wasn’t planning on publishing the next two weeks,…
-
340B, Affordable Care Act, Caught my eye, CMMI, Drug Prices, Home Health, Inflation Reduction Act, Medicare Advantage, Medicare Negotiation, Medicare Part D, Preventative, Reference Pricing, TariffsAMP is WAC — 12/5/25
Read more: AMP is WAC — 12/5/25It is the kind of month where I walk around with a legal pad to capture all the random thoughts floating around my head. Which is how “figure out gift baking (scones? Levain cookies?)” ends up next to “Look at MedPAC agenda.” There are no dull moments around here. While I’m on the topic. MedPAC…
-
340B, Affordable Care Act, CMMI, FDA, Inflation Reduction Act, Medicaid, Medicare Part D, State-based ReformAMP is WAC — 11/21/25
Read more: AMP is WAC — 11/21/25This week felt weirdly calm – I am sure I just jinxed it. No AMP is WAC next week. If something interesting happens, I’m sure I won’t be able to help myself and will post on LinkedIn. Have a great Thanksgiving and I hope you remember that nothing will change that person at the table,…
Latest news
- AMP is WAC — 04/24/26
- AMP is WAC — 04/10/26
- AMP is WAC — 03/27/26
- AMP is WAC — 03/20/26
- AMP is WAC — 03/13/26
Categories
- 340B (64)
- Affordable Care Act (23)
- Alzheimer's (11)
- Biosimilars (33)
- Caught my eye (102)
- Cell and Gene (8)
- Chevron Deference (2)
- CMMI (29)
- Copay Accumulators (7)
- COVID (3)
- Drug Prices (58)
- Drug shortages (15)
- DTC (9)
- Employers (20)
- FDA (8)
- Generics (13)
- Health Equity (4)
- Healthcare Costs (41)
- Home Health (1)
- ICER (12)
- Importation (5)
- Inflation Reduction Act (69)
- Insulin (7)
- IP (3)
- Long term care (1)
- Medicaid (24)
- Medicare Advantage (27)
- Medicare Negotiation (68)
- Medicare Part D (78)
- Medicare Transaction Facilitator (5)
- Medicare Transaction Facilitator (12)
- Obesity (28)
- On the Horizon (1)
- Orphan Drugs (8)
- Pharmacy Benefit Managers (49)
- Preventative (5)
- Reference Pricing (26)
- State-based Reform (32)
- Supply Chain (8)
- Tariffs (2)
- Uncategorized (9)
- Utilization Management (14)
- Vaccines (10)
- Value (18)